# Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

> **NCT06102863** · PHASE2 · RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 38 (estimated)

## Conditions studied

- Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I

## Interventions

- **DRUG:** statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);

## Key facts

- **NCT ID:** NCT06102863
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-01
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2025-04-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06102863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06102863, "Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06102863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*